On the 13 February 2020, the FSA publicly announced guidelines surrounding cannabidiol (CBD) for the industry. These guidelines contained a deadline of 31 March 2021 for CBD companies to submit a valid Novel Foods application to receive authorisation to be sold in the EU/UK market or risk enforcement.
For companies like Hempura that already operate to stringent requirements, the level of concern is almost nil about the inevitable ‘crackdown’, as the current Hempura product range is anticipated to meet any criteria already.
To read the full details, please click here.
Last Updated on 20/10/2020
All products on this website (www.Hempura.co.uk) are not advertised or sold as medicinal products or for any medicinal purposes. These products are not indended to diagnose, treat, cure or prevent any disease. These products are not to be used or purchased by persons under the age of 18. Use products strictly as advertised on the label. Keep out of reach of children. Do not use if pregnant or breastfeeding. You should consult with a physician before using the products or any other supplemental dietary product(s), particularly if you have a serious medical condition or are taking prescription medications.